A study that compared the responses in patients with varying severity of COVID-19 and acute dengue infection at different time-points showed significantly higher levels of IL-6, IL-10 and MIP-3α among those who developed COVID-19 pneumonia and DHF than those with mild manifestations (102). The gene discussed is IL6; the disease is COVID-19.